A ‘first in human’ clinical trial examining the small molecule drug ONC201 in cancer patients with advanced solid tumors shows that this investigational drug is well tolerated at the recommended phase II dose. That’s according to Rutgers Cancer...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2mUCAf7
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Sample Essay English Reckoning Poetry's Costs In Gwendolyn Brooks' First Fight. Then Fiddle. Grace can suggest a valuable beauty or ...
-
ARE GEISHA PROSTITUTES? There has long been a misunderstanding in western society that Geisha are prostitutes. There are two main reasons fo...
-
Overview (Based on a Mindtools article) Many people find that they learn best from , if they don’t reflect on their experience, and if they ...
-
Introduction. The conventional software development methodologies projects have failed to overcome the problem of volatility in the present ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oNSIRu via IFTTT
-
In The Advocate’s Women section, readers can find out the latest news and updates that are important to lesbian, bisexual, and transgender w...
-
Discovery Education AssessmentDiscovery Education Assessment Discovery Education Assessment Practice probes allow you toPractice probes allo...
-
Consulting to Finance: How to Network, Tell Your Story, Spin Your Resume, and Dominate Your Investment Banking and Private Equity Interviews...
-
Abstract Background Patients with a body mass index (BMI) >35 kg/m 2 who need kidney transplant present with increased postoperative...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου